Vericel Corporation (VCEL) Stock Price, Quote & News

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 588 5555

Fax: 617 588 5554

Website: www.vcel.com

Address:

64 Sidney Street, Cambridge, United States

Twister8 Oct. 23 at 5:26 PM

$VCEL trimmed some

0 · Reply

ceonner Oct. 18 at 6:52 PM

$VCEL 29 was an odd reversal spot. I thought we were donzo and back to 22. No longer trading this damn thing. No idea what it’s going to do. Still holding a long from 39 though.

1 · Reply

tackinis Oct. 16 at 1:26 AM

Bougth some $VADP, today bought $NEGG, $VCEL, still holding $NVNI . Good luck everyone

0 · Reply

copperhat Oct. 15 at 8:55 PM

$VCEL unbelievable

1 · Reply

JarvisFlow Oct. 15 at 4:19 PM

Truist Securities has adjusted their stance on Vericel ( $VCEL ), setting the rating to Buy with a target price of 46 → 41.

0 · Reply

copperhat Oct. 15 at 3:22 PM

$VCEL garbage

0 · Reply

tackinis Oct. 15 at 2:12 AM

$SDM Suck's to be sucked in this one, but I did Recover with $LAC $3 to $8, also got in into $NVNI, tomorrow entry $VCEL, also $ASST could be great recovery. Get some $VADP

1 · Reply

Twister8 Oct. 14 at 6:35 PM

$VCEL market buying into the q4 anticipated estimates

1 · Reply

copperhat Oct. 14 at 4:25 PM

$VCEL cheering quietly, I'm just about 15% down rn, better than 25% down

0 · Reply

copperhat Oct. 13 at 1:54 PM

$VCEL basically everything is screaming upwards today except this crap

0 · Reply

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Jul 31, 2025, 3:10 PM EDT - 3 months ago

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 8:08 AM EDT - 3 months ago

Vericel Reports Second Quarter 2025 Financial Results

Jul 17, 2025, 8:30 AM EDT - 3 months ago

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Jun 12, 2025, 10:23 AM EDT - 4 months ago

Vericel Corporation: Moving From Sell To Neutral

Jun 10, 2025, 8:30 AM EDT - 4 months ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

May 8, 2025, 1:52 PM EDT - 6 months ago

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 7:55 AM EDT - 6 months ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 7, 2025, 8:30 AM EDT - 6 months ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Apr 24, 2025, 8:30 AM EDT - 6 months ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Mar 5, 2025, 11:56 PM EST - 8 months ago

Vericel: Scalable Growth With Strong Margins

Mar 4, 2025, 8:30 AM EST - 8 months ago

Vericel to Present at Multiple Upcoming Investor Conferences

Feb 27, 2025, 1:05 PM EST - 8 months ago

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 7:54 AM EST - 8 months ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 13, 2025, 8:30 AM EST - 9 months ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Jan 15, 2025, 8:52 AM EST - 10 months ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

APLD CVGW

Jan 14, 2025, 4:05 PM EST - 10 months ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Dec 19, 2024, 12:50 PM EST - 11 months ago

Vericel Corporation: Hard To Justify Current Valuation

Nov 7, 2024, 1:52 PM EST - 1 year ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2024 Financial Results

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Aug 29, 2024, 9:17 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 26, 2024, 7:45 AM EDT - 1 year ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 7, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 1, 2024, 3:58 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2024 Financial Results

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jun 11, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 8, 2024, 2:36 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Apr 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Feb 29, 2024, 11:39 AM EST - 1 year ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 27, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 15, 2024, 8:30 AM EST - 1 year ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 5, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Jan 9, 2024, 7:55 AM EST - 1 year ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 3, 2024, 8:30 AM EST - 1 year ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Nov 8, 2023, 2:43 PM EST - 2 years ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 7:55 AM EST - 2 years ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 7, 2023, 8:30 AM EST - 2 years ago

Vericel to Present at the Stephens Annual Investment Conference

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Sep 28, 2023, 8:30 AM EDT - 2 years ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 20, 2023, 4:30 PM EDT - 2 years ago

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Sep 6, 2023, 8:30 AM EDT - 2 years ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference

Aug 2, 2023, 7:55 AM EDT - 2 years ago

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Jul 20, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

Twister8 Oct. 23 at 5:26 PM

$VCEL trimmed some

0 · Reply

ceonner Oct. 18 at 6:52 PM

$VCEL 29 was an odd reversal spot. I thought we were donzo and back to 22. No longer trading this damn thing. No idea what it’s going to do. Still holding a long from 39 though.

1 · Reply

tackinis Oct. 16 at 1:26 AM

Bougth some $VADP, today bought $NEGG, $VCEL, still holding $NVNI . Good luck everyone

0 · Reply

copperhat Oct. 15 at 8:55 PM

$VCEL unbelievable

1 · Reply

JarvisFlow Oct. 15 at 4:19 PM

Truist Securities has adjusted their stance on Vericel ( $VCEL ), setting the rating to Buy with a target price of 46 → 41.

0 · Reply

copperhat Oct. 15 at 3:22 PM

$VCEL garbage

0 · Reply

tackinis Oct. 15 at 2:12 AM

$SDM Suck's to be sucked in this one, but I did Recover with $LAC $3 to $8, also got in into $NVNI, tomorrow entry $VCEL, also $ASST could be great recovery. Get some $VADP

1 · Reply

Twister8 Oct. 14 at 6:35 PM

$VCEL market buying into the q4 anticipated estimates

1 · Reply

copperhat Oct. 14 at 4:25 PM

$VCEL cheering quietly, I'm just about 15% down rn, better than 25% down

0 · Reply

copperhat Oct. 13 at 1:54 PM

$VCEL basically everything is screaming upwards today except this crap

0 · Reply

kylejackson23 Oct. 11 at 1:58 PM

$VCEL

1 · Reply

Pro_From_Dover Oct. 10 at 3:13 PM

$VCEL undeniable piece of 💩

0 · Reply

Pro_From_Dover Oct. 10 at 2:18 PM

$VCEL back in Suxville.

0 · Reply

copperhat Oct. 10 at 2:11 PM

$VCEL down almost 5% since my last whine. brutal crap

1 · Reply

copperhat Oct. 8 at 10:33 PM

$VCEL $7.02 to go for my break even

0 · Reply

copperhat Oct. 7 at 8:19 PM

$VCEL wtf??? 2% drop in the last 19 minutes.this is one serious piece of degenerate crap

0 · Reply

copperhat Oct. 3 at 3:08 PM

$VCEL Another $7 to go for my break even

1 · Reply

LAMIGRA Oct. 3 at 2:51 PM

$VCEL low float runner

1 · Reply

copperhat Oct. 2 at 7:54 PM

$VCEL thats better

0 · Reply

copperhat Oct. 2 at 2:29 PM

$VCEL more crap

0 · Reply

Hedgeu2 Oct. 2 at 5:38 AM

$VCEL This is not the Vercel cloud platform company, people are angry about, don't short this.

0 · Reply

copperhat Oct. 1 at 7:49 PM

$VCEL crap, as per usual

0 · Reply

Market Cap	1.82B
Revenue (ttm)	237.22M
Net Income (ttm)	10.36M
EPS (ttm)	N/A
PE Ratio	303.58
Forward PE	185.24
Profit Margin	4.37%
Debt to Equity Ratio	0.00

Volume	350,300
Avg Vol	732,966
Day's Range	N/A - N/A
Shares Out	50.46M
Stochastic %K	84%
Beta	1.39
Analysts	Strong Sell
Price Target	$54.28